Clare Market Investments LLC Makes New $5.49 Million Investment in UnitedHealth Group Incorporated $UNH

Key Points

• Clare Market Investments LLC has invested approximately $5.49 million in UnitedHealth Group, acquiring 17,581 shares, which now represents about 1.2% of their total holdings.
• Several analysts have issued varying ratings for UnitedHealth Group, with Bank of America and Morgan Stanley increasing their price targets, while others like Baird have downgraded their ratings.
• UnitedHealth Group declared a quarterly dividend of $2.21, which will provide a yield of 2.6% for shareholders, and the dividend marks a payout ratio of 38.30%.

Clare Market Investments LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 17,581 shares of the healthcare conglomerate's stock, valued at approximately $5,485,000. UnitedHealth Group comprises approximately 1.2% of Clare Market Investments LLC's holdings, making the stock its 19th largest holding.

Other large investors have also modified their holdings of the company. Bayforest Capital Ltd lifted its stake in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its stake in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares in the last quarter. IAG Wealth Partners LLC acquired a new position in UnitedHealth Group during the 1st quarter worth about $42,000. Copia Wealth Management acquired a new position in UnitedHealth Group during the 4th quarter worth about $42,000. Finally, O Brien Wealth Partners LLC lifted its stake in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after acquiring an additional 37 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on UNH shares. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Robert W. Baird reiterated an "underperform" rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Bank of America raised their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a report on Monday, August 18th. Finally, Morgan Stanley increased their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.

UnitedHealth Group Price Performance

Shares of UNH opened at $334.74 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a market cap of $303.16 billion, a PE ratio of 14.50, a price-to-earnings-growth ratio of 2.23 and a beta of 0.45. The firm has a fifty day moving average price of $295.01 and a 200 day moving average price of $366.14.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the company earned $6.80 EPS. The business's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.